tanshinones in management of oral submucous fibrosis and oral squamous cell carcinoma

Clicks: 242
ID: 128305
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Oral submucous fibrosis is a premalignant condition predominantly occurring in Southeast Asian countries. Oral squamous cell carcinoma is the most common type of oral cancer. The current article highlights the promising benefits of the novel agent tanshinones (TSNs) in the management of oral submucous fibrosis and oral squamous cell carcinoma. The letter is written with the aim to promote more research on TSNs in the management of oral submucous fibrosis and oral squamous cell carcinoma.
Reference Key
shanbhag2017oncobiologytanshinones Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Vagish Kumar L Shanbhag
Journal oncobiology and targets
Year 2017
DOI
10.18639/ONBT.2017.04.456966
URL
https://onbt.scholasticahq.com/article/2032-tanshinones-in-management-of-oral-submucous-fibrosis-and-oral-squamous-cell-carcinoma
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.